Indivior to sell treatment rights to China's Zhejiang
Note: This section contains information in English only.
Mon, 04 Feb 2019 09:39:31 GMT
Source: Dukascopy Bank SA
The drugmaker Indivior stated on Monday it was selling the rights tied with its Chinese opioid addiction treatment Sai Bo Song to the privately-owned Zhejiang Pukang Biotechnology for about $122.5M.
For further information regarding potential cooperation, please call us or make callback request.
To learn more about Dukascopy Bank Binary Options
/ Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Business Introducer and other trading related information, please call us or make callback request.
For further information regarding potential cooperation, please call us or make callback request.